Natco Pharma Income Statement
Quarterly
Yearly
The current prices are delayed, login to your account to see live prices.
LOGIN
| 2021 | 2022 | 2023 | |
|---|---|---|---|
| EBITDA | 710 | 363 | 0 |
| EBIT | 593 | 220 | 0 |
| Earning Per Share | 24 | 9 | 39 |
| Expenses | 1,446 | 1,681 | 1,772 |
| Net Profit | 442 | 170 | 715 |
| Net Profit Margin | 22 | 9 | 26 |
| Operating Profit Margin | 35 | 19 | 38 |
| Profit Before Tax | 580 | 202 | 862 |
| Dividends Per Share | 5 | 5 | 0 |
| Operation Revenue | 2,156 | 2,044 | 2,812 |
Peer Comparison (in ₹.Cr.)
| Company | Year | EBIT | EBITDA | Net Profit | Net Worth | Profit Before Tax |
|---|---|---|---|---|---|---|
| 2023 | 0 | 0 | 80.62 | NA | 86.80 | |
| 2023 | 0 | 0 | 377.40 | NA | 868.45 | |
| 2023 | 0 | 0 | 447.69 | NA | 716.49 | |
| 2023 | 0 | 0 | 4,470.30 | NA | 6,011.50 | |
| 2023 | 0 | 0 | 8,560.84 | NA | 9,408.43 |
The current prices are delayed, login to your account to see live prices.
LOGIN
| 2013 | 2013 | 2013 | 2013 | 2015 | |
|---|---|---|---|---|---|
| Operating Activities | 61 | 61 | 61 | 61 | 93 |
| Investing Activities | -107 | -107 | -107 | -107 | -115 |
| Financing Activities | 26 | 26 | 26 | 26 | 29 |
| Others | 0 | 0 | 0 | 0 | 0 |
| Net Cash Flow | -20 | -20 | -20 | -20 | 7 |
Peer Comparison (in ₹.Cr.)
| Company | Year | Operating Activities | Investing Activities | Financing Activities | Net Cash Flow |
|---|---|---|---|---|---|
| 2022 | -17.75 | 18.85 | -5.82 | -4.72 | |
| 2020 | 1,392.41 | -783.52 | -444.66 | 164.23 | |
| 2020 | 1,468.84 | 1,106.99 | -890.58 | 1,685.25 | |
| 2016 | 3,262.60 | -2,039.40 | -1,700.10 | -476.90 | |
| 2018 | 3,907.15 | -3,370.81 | -1,539.26 | -1,002.92 |
Financials
All values are in Rs Cr